Qifeng He

1.5k total citations
23 papers, 942 citations indexed

About

Qifeng He is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Qifeng He has authored 23 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Qifeng He's work include Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Qifeng He is often cited by papers focused on Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Qifeng He collaborates with scholars based in China. Qifeng He's co-authors include Xiaochen Wang, Beicheng Sun, Haiyuan Shen, Anliang Xia, Wenfang Tian, Xiaojie Lu, Weiwei Yu, Huanhuan Wang, Weidi Yu and Yong Xu and has published in prestigious journals such as Advanced Materials, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Qifeng He

22 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qifeng He China 14 490 368 328 302 105 23 942
Baochi Ou China 17 602 1.2× 224 0.6× 403 1.2× 302 1.0× 114 1.1× 26 1.1k
Pierre‐Benoit Ancey France 10 555 1.1× 228 0.6× 185 0.6× 385 1.3× 71 0.7× 10 927
Haimeng Yan China 12 541 1.1× 314 0.9× 183 0.6× 230 0.8× 92 0.9× 25 944
Jingqin Lan China 10 804 1.6× 258 0.7× 170 0.5× 387 1.3× 95 0.9× 13 1.0k
Gang Shi China 16 433 0.9× 245 0.7× 162 0.5× 275 0.9× 54 0.5× 43 816
Yushuai Mi China 13 871 1.8× 253 0.7× 226 0.7× 618 2.0× 51 0.5× 19 1.2k
Xuefeng He China 13 764 1.6× 290 0.8× 218 0.7× 546 1.8× 50 0.5× 33 1.1k
Rufu Chen China 18 801 1.6× 197 0.5× 433 1.3× 546 1.8× 88 0.8× 41 1.2k
Jun Ye China 12 378 0.8× 232 0.6× 335 1.0× 243 0.8× 84 0.8× 18 850
Leyuan Zhou China 15 843 1.7× 259 0.7× 288 0.9× 762 2.5× 104 1.0× 37 1.3k

Countries citing papers authored by Qifeng He

Since Specialization
Citations

This map shows the geographic impact of Qifeng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qifeng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qifeng He more than expected).

Fields of papers citing papers by Qifeng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qifeng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qifeng He. The network helps show where Qifeng He may publish in the future.

Co-authorship network of co-authors of Qifeng He

This figure shows the co-authorship network connecting the top 25 collaborators of Qifeng He. A scholar is included among the top collaborators of Qifeng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qifeng He. Qifeng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ge, Zhongqi, et al.. (2025). Interacting roles of gut microbiota and T cells in the development of autoimmune hepatitis. Frontiers in Immunology. 16. 1584001–1584001. 2 indexed citations
2.
3.
Zeng, Xin, et al.. (2024). 6-Gingerol improves lipid metabolism disorders in skeletal muscle by regulating AdipoR1/AMPK signaling pathway. Biomedicine & Pharmacotherapy. 180. 117462–117462. 11 indexed citations
4.
Zeng, Yan, et al.. (2024). 6-Gingerol alleviates ectopic lipid deposition in skeletal muscle by regulating CD36 translocation and mitochondrial function. Biochemical and Biophysical Research Communications. 708. 149786–149786. 3 indexed citations
5.
Li, Dong, et al.. (2023). 6-Gingerol Ameliorates Hepatic Steatosis, Inflammation and Oxidative Stress in High-Fat Diet-Fed Mice through Activating LKB1/AMPK Signaling. International Journal of Molecular Sciences. 24(7). 6285–6285. 29 indexed citations
6.
Li, Dong, Yan Zeng, Ze Peng, et al.. (2023). Astragaloside IV Blunts Epithelial–Mesenchymal Transition and G2/M Arrest to Alleviate Renal Fibrosis via Regulating ALDH2-Mediated Autophagy. Cells. 12(13). 1777–1777. 13 indexed citations
7.
Lu, Yijun, Zechuan Zhang, Qifeng He, et al.. (2023). The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma. Journal of Hepatology. 79(5). 1172–1184. 27 indexed citations
9.
Wu, Pengkai, Haitian Zhang, Shuai Mao, et al.. (2022). Manipulating Offense and Defense Signaling to Fight Cold Tumors with Carrier‐Free Nanoassembly of Fluorinated Prodrug and siRNA. Advanced Materials. 34(38). e2203019–e2203019. 43 indexed citations
10.
Xia, Anliang, Wenwen Yuan, Qiang Wang, et al.. (2022). The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription. Nature Cancer. 3(2). 203–218. 73 indexed citations
11.
Du, Lei, Congrong Li, Qifeng He, et al.. (2020). Downregulation of the ubiquitin ligase KBTBD8 prevented epithelial ovarian cancer progression. Molecular Medicine. 26(1). 96–96. 8 indexed citations
12.
Wang, Xiaochen, Qifeng He, Haiyuan Shen, et al.. (2019). TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma. Journal of Hepatology. 71(4). 731–741. 213 indexed citations
13.
Zhang, Zechuan, Xiaoliang Xu, Wenfang Tian, et al.. (2019). ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation. Journal of Hepatology. 72(5). 976–989. 52 indexed citations
14.
Sun, Qikai, Qifeng He, Jianbo Xu, et al.. (2019). Guanine nucleotide–binding protein G(i)α2 aggravates hepatic ischemia‐reperfusion injury in mice by regulating MLK3 signaling. The FASEB Journal. 33(6). 7049–7060. 8 indexed citations
15.
He, Qifeng, Yong Xu, Jun Li, et al.. (2018). CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy. Briefings in Functional Genomics. 18(2). 99–106. 79 indexed citations
16.
Wang, Xiaochen, Haiyuan Shen, Guangyan Zhangyuan, et al.. (2018). 14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes. Cell Death and Disease. 9(2). 159–159. 115 indexed citations
17.
Wang, Xiaochen, Haiyuan Shen, Qifeng He, et al.. (2018). Exosomes derived from exhausted CD8+ T cells impaired the anticancer function of normal CD8+ T cells. Journal of Medical Genetics. 56(1). 29–31. 70 indexed citations
18.
Yu, Weidi, et al.. (2018). Long noncoding RNAs in cancer‐immunity cycle. Journal of Cellular Physiology. 233(9). 6518–6523. 98 indexed citations
19.
Xia, Anliang, Qifeng He, Jincheng Wang, et al.. (2018). Applications and advances of CRISPR-Cas9 in cancer immunotherapy. Journal of Medical Genetics. 56(1). 4–9. 40 indexed citations
20.
Wang, Xiaochen, Qifeng He, Haiyuan Shen, Xiaojie Lu, & Beicheng Sun. (2018). Genetic and phenotypic difference in CD8+ T cell exhaustion between chronic hepatitis B infection and hepatocellular carcinoma. Journal of Medical Genetics. 56(1). 18–21. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026